Market closed
ResMed/$RMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ResMed
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Ticker
$RMD
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
9,980
ISIN
US7611521078
Website
ResMed Metrics
BasicAdvanced
$36B
27.80
$8.91
0.76
$2.07
0.86%
Price and volume
Market cap
$36B
Beta
0.76
52-week high
$263.05
52-week low
$179.42
Average daily volume
1.3M
Dividend rate
$2.07
Financial strength
Current ratio
3.411
Quick ratio
1.957
Long term debt to equity
14.445
Total debt to equity
15.142
Dividend payout ratio (TTM)
23.14%
Interest coverage (TTM)
139.28%
Management effectiveness
Return on assets (TTM)
14.01%
Return on equity (TTM)
25.81%
Valuation
Price to earnings (TTM)
27.795
Price to revenue (TTM)
7.241
Price to book
6.55
Price to tangible book (TTM)
16.03
Price to free cash flow (TTM)
23.312
Dividend yield (TTM)
0.84%
Forward dividend yield
0.86%
Growth
Revenue change (TTM)
9.54%
Earnings per share change (TTM)
37.08%
3-year revenue growth (CAGR)
12.37%
3-year earnings per share growth (CAGR)
18.91%
3-year dividend per share growth (CAGR)
7.21%
What the Analysts think about ResMed
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for ResMed stock.
ResMed Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ResMed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ResMed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Jun12
ResMed
Dividend·Payment
$0.53Per share
FAQs
What’s the current market cap for ResMed stock?
ResMed (RMD) has a market cap of $36B as of May 14, 2025.
What is the P/E ratio for ResMed stock?
The price to earnings (P/E) ratio for ResMed (RMD) stock is 27.8 as of May 14, 2025.
Does ResMed stock pay dividends?
Yes, the ResMed (RMD) stock pays dividends to shareholders. As of May 14, 2025, the dividend rate is $2.07 and the yield is 0.86%. ResMed has a payout ratio of 23.14% on a trailing twelve-month basis.
When is the next ResMed dividend payment date?
The next ResMed (RMD) dividend payment is scheduled for June 12, 2025.
What is the beta indicator for ResMed?
ResMed (RMD) has a beta rating of 0.76. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.